Simplex Trading, LLC Travere Therapeutics, Inc. Transaction History
Simplex Trading, LLC
- $2.81 Billion
- Q3 2024
A detailed history of Simplex Trading, LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 40,461 shares of TVTX stock, worth $787,371. This represents 0.02% of its overall portfolio holdings.
Number of Shares
40,461
Previous 80,989
50.04%
Holding current value
$787,371
Previous $665,000
14.89%
% of portfolio
0.02%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding TVTX
# of Institutions
192Shares Held
83.6MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$149 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$149 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$134 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$91.2 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$84.5 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.25B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...